 Connection
Susan Calcaterra to Adult
This is a "connection" page, showing publications Susan Calcaterra has written about Adult.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.728 |
|
|
|
-
Scherbak Y, Wehrer M, Jacknin G, Nelson A, Calcaterra S. Bridging the Gap: Empowering Pharmacists in Inpatient Injectable Naltrexone and Hospital-Dispensed Methadone Process Development. J Am Coll Clin Pharm. 2026 Mar; 9(3):e70186.
Score: 0.046
-
Calcaterra SL, Weimer MB, Grimm E, Scherbak Y, Abdel Galil R, Berger O, Bowman LA, Nesbit SA, Barany A, Buresh ME. Leveraging the 72-Hour Rule Change to Support Transition From Hospital to Opioid Treatment Program. JAMA Netw Open. 2025 11 03; 8(11):e2544996.
Score: 0.045
-
Calcaterra SL, Lockhart S, Natvig C, Mikulich-Gilbertson SK. Measuring the Impact of a Multi-Site In-Hospital Intervention for Opioid Use Disorder Treatment Provision: A Survey of Hospital-Based Clinicians. J Gen Intern Med. 2026 03; 41(4):1048-1057.
Score: 0.044
-
Calcaterra SL, Mann S, Grimm E, Keniston A, Saunders S. Perspectives of In-Hospital Intramuscular Naltrexone and Oral Medications for Alcohol Use Disorder: A Study of Addiction Clinicians and Hospitalized Patients. J Gen Intern Med. 2025 09; 40(12):2981-2988.
Score: 0.042
-
Calcaterra SL, Yamkovoy K, Swathi PA, Ciccarone D, Del Pozo B, Englander H, Wang J, Barocas JA. U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019. Drug Alcohol Depend. 2024 09 01; 262:111409.
Score: 0.041
-
Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 07 25; 21(1):140.
Score: 0.041
-
Calcaterra SL, Grimm E, Keniston A. External validation of a model to predict future chronic opioid use among hospitalized patients. J Hosp Med. 2023 02; 18(2):154-162.
Score: 0.037
-
Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 09; 17(9):744-756.
Score: 0.036
-
Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 09; 17(9):679-692.
Score: 0.036
-
Calcaterra SL, Burnett-Hartman AN, Powers JD, Corley DA, McMullen CM, Pawloski PA, Feigelson HS. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer. 2020 May 03; 20(1):373.
Score: 0.031
-
Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029.
Score: 0.029
-
Calcaterra SL, Hopfer CJ, Keniston A, Hull ML. Changes in Healthcare Encounter Rates Possibly Related to Cannabis or Alcohol following Legalization of Recreational Marijuana in a Safety-Net Hospital: An Interrupted Time Series Analysis. J Addict Med. 2019 May/Jun; 13(3):201-208.
Score: 0.029
-
Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, Dart RC. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clin Toxicol (Phila). 2018 11; 56(11):1107-1114.
Score: 0.027
-
Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. J Gen Intern Med. 2018 06; 33(6):898-905.
Score: 0.026
-
Calcaterra SL, Drabkin AD, Doyle R, Leslie SE, Binswanger IA, Frank JW, Reich JA, Koester S. A Qualitative Study of Hospitalists' Perceptions of Patient Satisfaction Metrics on Pain Management. Hosp Top. 2017 Jan-Mar; 95(1):18-26.
Score: 0.024
-
Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. J Gen Intern Med. 2016 May; 31(5):478-85.
Score: 0.023
-
Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA. The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System. Subst Abus. 2015; 36(4):407-12.
Score: 0.022
-
Calcaterra SL, Beaty B, Mueller SR, Min SJ, Binswanger IA. The association between social stressors and drug use/hazardous drinking among former prison inmates. J Subst Abuse Treat. 2014 Jul; 47(1):41-9.
Score: 0.020
-
Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70.
Score: 0.019
-
Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2):129-36.
Score: 0.019
-
Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun; 6(2):97-105.
Score: 0.018
-
Donroe JH, Calcaterra SL, Simon C, Weimer MB, Huxley-Reicher Z, Puglisi LB, Torres-Lockhart K, Hall OT, Bhandary-Alexander J, Encandela J, Martin M. Recommendations for Addressing In-Hospital Substance Use From a National Delphi Consensus Process. JAMA Netw Open. 2025 08 01; 8(8):e2528703.
Score: 0.011
-
Lebin JA, Mitchell K, Trinkley KE, Calcaterra SL, Lun Z, Hensen C, Hoppe JA. Clinical Decision Support to Increase Naloxone Co-prescribing from the Inpatient Setting. J Gen Intern Med. 2026 01; 41(1):18-25.
Score: 0.011
-
Callister C, Porter S, Vatterott P, Keniston A, McBeth L, Mann S, Calcaterra SL, Limes J. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder. Subst Use Addctn J. 2024 07; 45(3):356-366.
Score: 0.010
-
Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019; 40(1):71-79.
Score: 0.007
-
Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". J Hosp Med. 2018 09; 13(10):728.
Score: 0.007
-
Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653.
Score: 0.007
-
Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
Score: 0.006
-
Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain Med. 2016 10; 17(10):1838-1847.
Score: 0.006
-
Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug Alcohol Depend. 2015 Dec 01; 157:150-7.
Score: 0.006
-
Lalle E, Calcaterra S, Horejsh D, Abbate I, D'Offizi G, Abdeddaim A, Vlassi C, Antonucci G, Capobianchi MR. Ability of peripheral blood mononuclear cells to activate interferon response in vitro is predictive of virological response in HCV patients. J Biol Regul Homeost Agents. 2008 Jul-Sep; 22(3):153-60.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|